IL4Ra blockade reduces Oral Immunotherapy outcome-related adverse events through inhibition of mast cell activity in a murine model of oral immunotherapy

Journal of Allergy and Clinical Immunology 2026

View at publisher

Authors: Amanda Atanasio, Varsha Ganesan, Abigail von Recklinghausen, Lea Maney, André Limnander, Jamie Marie Orengo, Simon Hogan

DOI: 10.1016/j.jaci.2025.12.469

Cited by: 0

Fields of Study & Subjects

Food Allergy and Anaphylaxis Research Allergic Rhinitis and Sensitization Asthma and respiratory diseases